期刊文献+

腹腔多次注射STZ对KM种小鼠血液及胰岛细胞的影响 被引量:1

Effects of multiple intraperitoneal injections of STZ on blood indice and islet cells in KM mice
下载PDF
导出
摘要 目的:研究小鼠腹腔多次注射不同剂量STZ对KM种小鼠血液学及胰岛细胞的影响.方法:SPF级昆明种雄性小白鼠(24~28 g),随机分为阴性对照组和3个STZ腹腔注射组,分别为45、35、25 mg/kg·bw剂量组(n=15).各剂量组腹腔多次注射STZ,每次注射后进行空腹血糖检测,并于实验结束时进行血ALT、AST、TP、ALB含量、尿糖含量及PLT、MPV、PCT、PDW测定,同时取胰腺进行组织病理学检查.结果:45 mg/kg·bw剂量组腹腔注射STZ一次,35、25 mg/kg·bw剂量组注射两次,均可显著升高实验动物血糖值(P<0.05);45、35 mg/kg·bw剂量组注射三次后,诱导糖尿病动物模型的成模率分别为93.3%、73.3%,两组的AST、ALT、PLT、尿糖值均高于阴性对照组,但TP、ALB含量低于阴性对照组(P<0.05);胰腺组织病理学检查表明STZ可损伤胰岛细胞,并以45 mg/kg·bw剂量组胰岛细胞损伤最为严重.结论:腹腔注射STZ三次可损伤胰岛细胞,35 mg/kg·bw以上剂量可明显改变实验动物的血生化指标和PLT水平,45 mg/kg·bw剂量的STZ可诱导较为理想的糖尿病动物模型. Objective :To explore the effects of STZ on blood indice and islet cells changes of mice after being multiply injected intraperitoneally. Methods: The 24 - 28 g KM male mice of SPF were randomly divided into control group and three STZ - treated groups (45,35,25 mg/kg·bw separately) by their weight( n = 15). Animals in STZ groups were multiply injected with STZ intraperitonially, and Glu was measured after each injection. When finishing the experiment, blood indice including ALT, AST,TP, ALB, urine glucose, and PLT,MPV,PCT,PDW were assayed, and pathological changes of pancreas were examined through HE staining. Results:STZ was injected intraperitoneally for once in 45 mg/kg · bw group, twice in 35 mg/kg·bw group, could significantly increase Glu level(P 〈0. 05). After injection for three times,STZ dose of 45 mg/kg· bw and 35 mg/kg·bw could successfully induce diabetes model (93.3% and 73.3% ), and increase the level of ALT, AST, PLT and urine glucose, but lower the level of TP and ALB(P 〈0. 05). Pathological observation of pancreas showed islet cells injury in 45 mg/kg ·bw group were injured the most. Conclusion:Multiple injected STZ intraperitonially for there times could injure islet cells, and STZ above 35 mg/ kg·bw promotes indice of blood biochemistry and PLT changed obviously. The 45 mg/kg · bw of STZ injected three times intraperitoneally could make an ideal diabetes model.
出处 《中国卫生检验杂志》 CAS 2007年第8期1371-1373,共3页 Chinese Journal of Health Laboratory Technology
基金 广东省科技厅科研条件建设计划课题(2006B60101061) 广东省社会发展领域科技计划项目(53071)
关键词 链脲佐菌素 糖尿病 血液生化 血小板 胰腺 小鼠 STZ Diabetes Blood biochemistry PLT Pancreas Mice
  • 相关文献

参考文献9

  • 1Yang Z,Chen M,Fialkow LB,et al.The novel anti -inflammatory compound,lisofyline,prevents diabetes in multiple low-dose strevozotocin -treated mice[J].Pancreas,2003,26(4):99-104.
  • 2Saini KS,Thompson C,Winterford CM,et al.Streptozotocin at low dose induces apoptosis and at high doses cause necrosis in a murine pancreatic beta cell line[J].Biochen Mol Bio1,1996,39(6):1229 -1236.
  • 3.保健食品检验与评价技术规范[S].[S].中华人民共和国卫生部,2003.223-224.
  • 4Reed MJ,Meszaros K.A new rat model of type 2 diabetes:the fat-fed,streptozotocin-treated rat[J].Metabolism,2000,49 (11):1390-1394.
  • 5Rossini AA,Williams RM,Appel MC,et al.Sex difference in the multiple-dose streptozotocin model of diabetes[J].Endocrinology,1978,103(4):1518-1520.
  • 6童书云,李郑芳,陈晓群,詹列兵,于南南,戴丽芬.糖尿病患者血小板膜糖蛋白CD62P和CD63表达及其临床意义研究[J].云南医药,2005,26(4):302-304. 被引量:1
  • 7Hekimsoy Z,Payzin B,Omet T,et al.Mean p latelet volume in type 2diabetic patients[J].J Diabetes Complications,2004,18 (3):173 -176.
  • 8萧丽军,武晓泓,孙敏,刘超,何戎华.类固醇药物性糖尿病46例临床分析[J].辽宁实用糖尿病杂志,2004,12(4):44-45. 被引量:11
  • 9田丽艳,范建高,钱燕,蔡晓波.链脲佐菌素糖尿病大鼠的肝脏损伤[J].肝脏,2005,10(2):135-136. 被引量:6

二级参考文献13

  • 1[2]Friedman TC, Mastorakos G, Newman TD, et al. Carbohydrate and lipid metabolism in endogenous hypercortisolism shared features with metabolic syndrome X and NIDDM. Endocr J 1996;43(6):645-655.
  • 2NOMURA S. Platelet activation marker [J]. Clin Exp Immunol, 2000, 121 (3): 437-443.
  • 3GRIESSHAMMER M, BENEKE H, NUSSBAUMEER B,et al. Increased platelet surface expression of p - selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia [ J ], Thrombosis Res, 1999,2: 191- 198.
  • 4NOMURA S, SHOUZU A, OMOTO S, et al. Significance of chemokines and activated platelets in patients with diabetes [J]. Clin Exp Immunol, 2000, 121 (3): 437-443.
  • 5HAGBERG IA, LYBERG T. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies [J]. Platelets, 2000, 11 (3): 137- 150.
  • 6OMOTO S, NOMURA S, SHOUZU A, et al. Significance of platelet- derived microparticles and activated platelets in diabetic nephropathy [J ]. Eur J Clin Invest, 2004,34 (3): 205-209.
  • 7EIBL N, KRUGLUGER W, STREIT G, et al. Improved metabolic control decreases platelet activation markers in patients with type - 2 diabetes [ J ]. Thromb Res, 2003,10 (4): 203-208.
  • 8TAKASHASHI Y, FUDA H, YANAI H, et al. Significance of membrane glycoproteins in platelet interaction with oxidized low - density lipoprotein [ J ]. Semin Thromb Hemost, 1998, 24 (3): 251 - 253.
  • 9MATSUMOTO K, SERA Y, UEK1 Y, et al. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy [ J ].Nephron, 1999, 81 (3): 271-277.
  • 10PERNOLLET MG, LANTOINE F, DEVYNET MA. Nitric oxide inhibits ATP - dependent Ca^2+ uptake into platelet membrane vesicles [ J ]. Biochenl Biophys Res Comman, 1996, 222 (3): 780-785.

共引文献259

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部